α5IA
CAS: 215874-86-5
Ref. 3D-QIA87486
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Product Information
Alpha5IA is a benzodiazepine-binding compound that inhibits the activity of the gamma-aminobutyric acid type A receptor. It has been shown to inhibit neuronal death in mouse hippocampal cells and is being developed as a potential treatment for Alzheimer's disease. Alpha5IA has also been shown to have clinical efficacy in humans, with minimal side effects. This drug is nonselective, meaning that it is active at all GABA receptors, but it does not cross the blood-brain barrier. Alpha5IA has been used in clinical pharmacology studies to evaluate its efficacy and safety profile in humans, and has shown promising results.
Chemical properties
Technical inquiry about: 3D-QIA87486 α5IA
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
